SCOPUS 정보 검색 플랫폼

Volumn 83, Issue 12, 2000, Pages 1612-1616

Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma

(5) Mulatero, C a McClaren, B R a Mason, M b Oliver, R T D a Gallagher, C J a

a ST BARTHOLOMEW S HOSPITAL (United Kingdom)

b VELINDRE CANCER CENTRE (United Kingdom)

Author keywords

Cisplatin; Paclitaxel; Schedule; Transitional cell; Vinblastine

Indexed keywords

CHLORPHENIRAMINE; CIMETIDINE; CISPLATIN; DEXAMETHASONE; PACLITAXEL; VINBLASTINE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DRUG EFFICACY; DRUG INHIBITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MYALGIA; NEPHROTOXICITY; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TRANSITIONAL CELL CARCINOMA;

AGED; ALOPECIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; CONSTIPATION; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; NAUSEA; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM DISEASES; STOMATITIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; VINBLASTINE; VOMITING;

EID: 0034545879 PISSN: 00070920 EISSN: None Source Type: Journal
DOI: 10.1054/bjoc.2000.1480 Document Type: Article

Times cited : (8)

References (31)

1
- 0003260593
- M-VAC in transitional cell carcinoma (TCC): Prognostic factors and long-term survival in 203 Patients (Pts)
- Abstr.
- (1998) Proceedings of ASCO , vol.17 , pp. 1198
- Bajorin, D.¹ Dodd, P.² McCaffrey, J.³ Mazumdar, M.⁴ Vlamis, V.⁵ Herr, H.⁶ Boyle, M.⁷ Scher, H.⁸ Higgins, G.⁹

2
- 0031903265
- Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: A phase II trial
- (1998) Journal of Clinical Oncology , vol.16 , pp. 2722-2727
- Bajorin, D.F.¹ McCaffrey, J.A.² Hilton, S.³ Mazumdar, M.⁴ Kelly, W.K.⁵ Scher, H.I.⁶ Spicer, J.⁷ Herr, H.⁸ Higgins, G.⁹

3
- 0000115909
- A phase II trial of paclitaxel, cisplatin and gemcitabine (TCG) in patients (pts) with advanced transitional cell carcinoma (TCC) of the urothelium
- Abstr.
- (1999) Proceedings of ASCO , vol.18 , pp. 1279
- Bellmunt, J.¹ Guillem, V.² Paz-Ares, L.³

4
- 0019998174
- Phase II trial of vinblastine sulfate for metastatic urothelial tract tumors
- (1982) Cancer , vol.50 , pp. 435-438
- Blumenreich, M.S.¹ Yagoda, A.² Natale, R.B.³ Watson, R.C.⁴

5
- 0028804038
- Accelerated cisplatin-based chemotherapy for advanced bladder cancer
- (1995) European Journal of Cancer , vol.31 A , pp. 1633-1636
- Boshoff, C.¹ Oliver, R.T.² Gallagher, C.J.³ Ong, J.⁴

6
- 0000115913
- Phase II trial of combination paclitaxel and cisplatin in advanced urothelial carcinoma
- Abstr.
- (1999) Proceedings of ASCO , vol.18 , pp. 1266
- Burch, P.¹ Richardson, R.² Cha, S.³ Sargent, D.⁴ Pitot, H.⁵ Kaur, J.⁶ Camoriano, J.⁷

7
- 0006798941
- Dose-intense M-Vac (Di-M-VAC) does not impact survival relative to standard M-VAC (M-VAC) in patients (Pts) with transitional cell carcinoma (TCC)
- Abstr.
- (1998) Proceedings of ASCO , vol.17 , pp. 1223
- Dodd, P.¹ Mccaffrey, J.² Vlamis, M.M.³ Higgins, G.⁴ Boyle, M.⁵ Herr, H.⁶ Scher, H.⁷ Bajorin, D.⁸

8
- 0000839333
- E2895 cisplatin and paclitaxel in advanced carcinoma of the urothelium: A phase II trial of the Eastern cooperative oncology group (ECOG)
- Abstr.
- (1998) Proceedings of ASCO , vol.17 , pp. 1233
- Dreicer, R.¹ Roth, B.² Lipsitz, S.³ Cohen, M.⁴ See, W.⁵ Wilding, G.⁶

9
- 0032484528
- Combinations of paclitaxel and vinblastine and their effects on tubulin polymerization and cellular cytotoxicity: Characterization of a synergistic schedule
- (1998) International Journal of Cancer , vol.75 , pp. 57-63
- Giannakakou, P.¹ Villalba, L.² Li, H.³ Poruchynsky, M.⁴ Fojo, T.⁵

10
- 0022360630
- Cisplatin, methotrexate, and vinblastine (CMV): An effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study
- (1985) J Clin Oncol , vol.3 , pp. 1463-1470
- Harker, W.G.¹ Meyers, F.J.² Freiha, F.S.³ Palmer, J.M.⁴ Shortliffe, L.D.⁵ Hannigal, J.F.⁶ McWhirter, K.M.⁷ Torti, F.M.⁸

11
- 0017348988
- Assessement of response to therapy in advanced breast cancer
- (1977) Br J Cancer , vol.35 , pp. 292-298
- Hayward, J.L.¹ Carbone, P.P.² Heusen, J.C.³ Kumaoka, S.⁴ Segaloff, A.⁵ Rubens, R.D.⁶

12
- 0018945909
- Cis-diamminedichloride platinum II in the treatment of advanced bladder cancer
- (1980) J Urol , vol.123 , pp. 853-855
- Herr, H.W.¹

13
- 0028158664
- Synergistic interaction between cisplatin and Taxol in human ovarian carcinoma cells in vitro
- (1994) Br J Cancer , vol.69 , pp. 299-306
- Jekunen, A.P.¹ Christen, R.D.² Shalinsky, D.R.³ Howell, S.B.⁴

14
- 0026625220
- A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study
- published erratum appears in J Clin Oncol 1993 Feb; 11 (2);384
- (1992) J Clin Oncol , vol.10 , pp. 1066-1073
- Loehrer P.J., Sr.¹ Einhorn, L.H.² Elson, P.J.³ Crawford, E.D.⁴ Kuebler, P.⁵ Tannock, I.⁶ Raghavan, D.⁷ Stuart-Harris, R.⁸ Sarosdy, M.F.⁹ Lowe, B.A.¹⁰

15
- 0018149097
- Treatment of advanced bladder cancer with cisdiamminedichloroplatinum (II NSC 119875): A pilot study
- (1978) J Urol , vol.119 , pp. 493-495
- Merrin, C.¹

16
- 0002575775
- Phase II trial of paclitaxel (P) and cisplatin (C) for metastatic or locally unresectable urothelial Cancer
- Abstr.
- (1996) Proceedings of ASCO , vol.15 , pp. 617
- Murphy, B.¹ Smith, J.² Koch, M.³ DeVore, R.⁴ Blanke, C.⁵

17
- 0019473774
- Methotrexate: An active drug in bladder cancer
- (1981) Cancer , vol.47 , pp. 1246-1250
- Natale, R.B.¹ Yagoda, A.² Watson, R.C.³ Whitmore, W.F.⁴ Blumenreich, M.⁵ Braun D.W., Jr.⁶

18
- 0019489602
- A phase 2 study of Cis-platinum in patients with recurrent bladder carcinoma. The London and Oxford Co-operative Urological Cancer Group
- (1981) Br J Urol , vol.53 , pp. 444-447
- Oliver, R.T.¹ Newlands, E.S.² Wiltshaw, E.³ Malpas, J.S.⁴

19
- 0021366049
- Methotrexate in the treatment of metastatic and recurrent primary transitional cell carcinoma
- (1984) J Urol , vol.131 , pp. 483-485
- Oliver, R.T.¹ England, H.R.² Risdon, R.A.³ Blandy, J.P.⁴

20
- 0031052826
- Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter
- (1997) British Journal of Cancer , vol.75 , pp. 606-607
- Papamichael, D.¹ Gallagher, C.J.² Oliver, R.T.³ Johnson, P.W.⁴ Waxman, J.⁵

21
- 0031014450
- Cancer statistics, 1997
- published erratum appears in CA Cancer J Clin 1997 Mar-Apr:47(2):68
- (1997) Ca: Cancer Journal for Clinicians , vol.47 , pp. 5-27
- Parker, S.L.¹ Tong, T.² Bolden, S.³ Wingo, P.A.⁴

22
- 0018836278
- Cis-diamminedichloroplatinum as a therapeutic agent in metastatic transitional cell carcinoma
- (1980) J Urol , vol.123 , pp. 375-377
- Peters, P.C.¹

23
- 0018579143
- Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: A Southwest Oncology Group Study
- (1979) Cancer Treat Rep , vol.63 , pp. 1605-1608
- Rossof, A.H.¹ Coltman C.A., Jr.² Jones, S.E.³ Talley, R.W.⁴

24
- 0027999651
- Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: A phase II trial of the Eastern Cooperative Oncology Group
- (1994) J Clin Oncol , vol.12 , pp. 2264-2270
- Roth, B.J.¹ Dreicer, R.² Einhorn, L.H.³ Neuberg, D.⁴ Johnson, D.H.⁵ Smith, J.L.⁶ Hudes, G.R.⁷ Schultz, S.M.⁸ Loehrer, P.J.⁹

25
- 0027501314
- Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine
- (1993) J Cancer Res Clin Oncol , vol.119 , pp. 727-733
- Rowinsky, E.K.¹ Citardi, M.J.² Noe, D.A.³ Donehower, R.C.⁴

26
- 0021910302
- Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium
- (1985) Journal of Urology , vol.133 , pp. 403-407
- Sternberg, C.N.¹ Yagoda, A.² Scher, H.I.³ Watson, R.C.⁴ Ahmed, T.⁵ Weiselberg, L.R.⁶ Geller, N.⁷ Hollander, P.S.⁸ Herr, H.W.⁹ Sogani, P.C.¹⁰

27
- 0028877082
- Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies
- (1995) J Urol , vol.154 , pp. 1719-1722
- Tu, S.M.¹ Hossan, E.² Amato, R.³ Kilbourn, R.⁴ Logothetis, C.J.⁵

28
- 0000115915
- Phase II evaluation of carboplatin, paclitaxel and gemcitabine in advanced urothelial carcinoma
- Abstr.
- (1999) Proceedings of ASCO , vol.18 , pp. 1282
- Vaishampayan, U.¹ Smith, D.² Redman, B.³ Kucuk, O.⁴ Ensley, J.⁵ Hussain, M.⁶

29
- 0023179686
- Chemotherapy of urothelial tract tumors
- (1987) Cancer , vol.60 , pp. 574-585
- Yagoda, A.¹

30
- 0017186714
- Cis-dichlorodiammineplatinum(II) in advanced bladder cancer
- (1976) Cancer Treat Rep , vol.60 , pp. 917-923
- Yagoda, A.¹ Watson, R.C.² Gonzalez-Vitale, J.C.³ Grabstald, H.⁴ Whitmore, W.F.⁵

31
- 0017344466
- Adriamycin in advanced urinary tract cancer: Experience in 42 patients and review of the literature
- (1977) Cancer , vol.39 , pp. 279-285
- Yagoda, A.¹ Watson, R.C.² Whitmore, W.F.³ Grabstald, H.⁴ Middleman, M.P.⁵ Krakoff, J.H.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.